Leadership February 02, 2022 RoslinCT Boston (former Lykan Bioscience) Welcomes Jay Blackington as Head of People and Culture
Cell Therapy, Investment, Partnerships January 11, 2022 GHO Capital invests in RoslinCT, a leading cell therapy CDMO
Facilities, Site Expansion February 05, 2021 RoslinCT announces the establishment of a Cell and Gene Training Academy